Valeant Pharmaceuticals International Mourns Death Of Chairman Robert W. O’Leary; Board Of Directors Elects Robert A. Ingram As Chairman Of The Board

Valeant Pharmaceuticals International (NYSE:VRX) announced with great sadness today that Robert W. O’Leary, who served as its chairman of the board over the past four years, died this morning at the age of 62, following a long battle with cancer.